Krsnaa Diagnostics (NSE:KRSNAA) Debt-to-Equity: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KRSNAA Krsnaa Diagnostics Ltd NSE:KRSNAA
72 GF Score
Price ₹541.65
GF Value ₹924.90
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Krsnaa Diagnostics Debt-to-Equity?

Krsnaa Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. Krsnaa Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. Krsnaa Diagnostics's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Krsnaa Diagnostics's Debt-to-Equity or its related term are showing as below:

NSE:KRSNAA' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.99   Med: 0.14   Max: 1
Current: 0.55

During the past 8 years, the highest Debt-to-Equity Ratio of Krsnaa Diagnostics was 1.00. The lowest was -1.99. And the median was 0.14.

NSE:KRSNAA's Debt-to-Equity is ranked worse than
68.72% of 179 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.3 vs NSE:KRSNAA: 0.55

Krsnaa Diagnostics  (NSE:KRSNAA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Krsnaa Diagnostics Debt-to-Equity Related Terms

Krsnaa Diagnostics Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Krsnaa Diagnostics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics Debt-to-Equity Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
Get a 7-Day Free Trial 0.06 0.04 0.20 0.23 0.55

Krsnaa Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.31 N/A 0.55 N/A

NSE:KRSNAA vs TMO, DHR, NTRA: Debt-to-Equity Comparison

For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Krsnaa Diagnostics Debt-to-Equity vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Krsnaa Diagnostics's Debt-to-Equity falls into.


NSE:KRSNAA
72GF Score
Krsnaa Diagnostics Ltd NSE:KRSNAA
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krsnaa Diagnostics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Krsnaa Diagnostics's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(660.24 + 4371.44) / 9803.88
=0.51

Krsnaa Diagnostics's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + 0) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?

Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued. The current stock price of ₹541.65 is trading 41.4% below its estimated GF Value™ of ₹924.90. GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.

Key valuation signals for NSE:KRSNAA:

  • Debt-to-Equity: N/A
  • GF Value™: ₹924.90 vs. price of ₹541.65 (41.4% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krsnaa Diagnostics Business Description

Other Exchanges 543328:India
Address S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
72GF Score

Get the complete analysis for NSE:KRSNAA

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹541.65
Price
₹924.90
GF Value